A DENSTONE man who suffered a heart attack on his 77th birthday has been left with no rehabilitation for more than a month after a cut in services.
Colin Dibblee, of The Weavers, suffered the attack at the beginning of May but since the cardiac rehabilitation service was cut in Uttoxeter by the East Staffordshire Clinical Commissioning Group (CCG) and the leisure centre is under development he has been left with no support in Uttoxeter.
The couple was also told the service from Balance Street Surgery is no longer available.
His wife Christine told The Advertiser they have had no contact from the hospital at all since he had the attack while on holiday.
She said: “I have spoken to our GP as we had not heard anything and he is going to try and arrange for rehabilitation in Derby but how does he get there?
“He can’t drive for six months and this is way out of town, just simply because there is nothing in Uttoxeter. Heart attacks are unexpected and the fact they had rehabilitation in Uttoxeter showed that enough people were using it.
“My husband was a very active person and if he had started rehabilitation at home it would help him on the road to recovery.”
Dr Charles Pidsley, CCG chairman, said they commission cardiac rehabilitation services for all patients in East Staffordshire and all patients should have access to cardiac rehabilitation if required.
He said “Until recently, an additional service for patients assessed as ‘low-risk’ was available locally in Uttoxeter. Unfortunately the provider deemed it financially unfeasible to continue and chose not to renew the contract.
“It’s essential that cardiac rehabilitation, for all but those deemed ‘low-risk’, is carried out in an appropriate environment where patients are safe and can be properly monitored and cared for.
“The current service provided by Burton Hospitals NHS Foundation Trust meets all those requirements and the CCG meets regularly with the trust to review and monitor the service. As part of those regular conversations we have asked the trust to look into the possibility of providing a replacement in Uttoxeter.”